ALL

News

Drug could be repurposed for T-ALL

Venetoclax might improve the treatment of certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to preclinical research...

MD IQ

News

Adult CCSs report financial hardships

Health-related financial hardship is common among adult survivors of childhood cancer, according to a study published in the Journal of the...

News

Global burden of hematologic malignancies

Research has shown an increase in the global incidence of leukemia and non-Hodgkin lymphoma (NHL) in recent years. The Global Burden of Disease (...

News

FDA approves biosimilar filgrastim

The US Food and Drug Administration (FDA) has approved the leukocyte growth factor Nivestym™ (filgrastim-aafi), a biosimilar to Neupogen (...

Pages